Cargando…
Old drugs with new skills: fenoprofen as an allosteric enhancer at melanocortin receptor 3
The efficiency of drug research and development has paradoxically declined over the last decades despite major scientific and technological advances, promoting new cost-effective strategies such as drug repositioning by systematic screening for new actions of known drugs. Here, we performed a screen...
Autores principales: | Montero-Melendez, Trinidad, Forfar, Rachel A. E., Cook, Jennifer M., Jerman, Jeffrey C., Taylor, Debra L., Perretti, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346439/ https://www.ncbi.nlm.nih.gov/pubmed/27853832 http://dx.doi.org/10.1007/s00018-016-2419-3 |
Ejemplares similares
-
Ligand Bias and Its Association With Pro-resolving Actions of Melanocortin Drugs
por: Patruno, Sara, et al.
Publicado: (2018) -
Curbing Inflammation through Endogenous Pathways: Focus on Melanocortin Peptides
por: Ahmed, Tazeen J., et al.
Publicado: (2013) -
Melanocortin Receptors as Novel Effectors of Macrophage Responses in Inflammation
por: Patel, Hetal B., et al.
Publicado: (2011) -
Editorial: Melanocortins and melanocortin receptors in the regulation of inflammation: mechanisms and novel therapeutic strategies
por: Rinne, Petteri, et al.
Publicado: (2023) -
Identification of a novel specific small-molecule melanocortin-2-receptor antagonist
por: Forfar, Rachel, et al.
Publicado: (2022)